U-ACTIVATE long-term efficacy and safety outcomes for upadacitinib in ulcerative colitis. Noor NM, Parkes M, Raine T. Lancet Gastroenterol Hepatol 2025;10:492-493.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Noor NM, Parkes M, Raine T. U-ACTIVATE long-term efficacy and safety outcomes for upadacitinib in ulcerative colitis. Lancet Gastroenterol Hepatol 2025;10:492-493.
PMID: 40347952